AMI
In clinical practice,       patients with AMI, not included in current randomized trials comparing primary       angioplasty with thrombolysis, account for 22% of all patients with AMI treated       with one of those two therapies.
In clinical practice,       patients with AMI, not included in current randomized trials comparing primary       angioplasty with thrombolysis, account for 22% of all  @OBJECT$   @PREDICAT$   @SUBJECT$  treated       with one of those two therapies.